Cytosorbents
CTSO
#10163
Rank
NZ$53.5 M
Marketcap
NZ$0.85
Share price
-8.16%
Change (1 day)
-44.27%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$22.55 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.97 Million. In 2024 the company made an earning of -NZ$38.92 Million, an increase over its 2023 earnings that were of -NZ$50.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$22.55 Million-42.05%
2024 -NZ$38.92 Million-22.49%
2023 -NZ$50.21 Million-13.52%
2022 -NZ$58.06 Million34.04%
2021 -NZ$43.32 Million182.17%
2020 -NZ$15.35 Million-55.97%
2019 -NZ$34.86 Million14.17%
2018 -NZ$30.54 Million95.14%
2017 -NZ$15.65 Million-22.32%
2016 -NZ$20.15 Million39.1%
2015 -NZ$14.48 Million-12.89%
2014 -NZ$16.63 Million89%
2013 -NZ$8.8 Million26.65%
2012 -NZ$6.95 Million-26.02%
2011 -NZ$9.39 Million-288.45%
2010 NZ$4.98 M-4.17%
2009 NZ$5.19 M-287.19%
2008 -NZ$2.78 Million-47.12%
2007 -NZ$5.26 Million41.78%
2006 -NZ$3.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.40 B-29,618.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.33 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
NZ$95.04 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA